We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




DNA Research Reveals Complicated Human Origins in Africa

By LabMedica International staff writers
Posted on 08 Oct 2012
The Khoe and San peoples in southern Africa are playing an important role for a more comprehensive understanding of the evolutionary history of humans, according to new genetic data. More...
These people are directly descended from the first branching of the genealogic tree of modern-day humans.

The study was led by Uppsala University (Sweden) researchers and the findings were published in the early online version of the journal Science September 20, 2012. The study is based on an analysis of 2.3 million genetic variants from seven groups of the Khoe and San peoples, a total of 220 individuals from southern Africa. The analysis is the largest genetic study ever of the Khoe and San peoples.

The study demonstrated that most people who self-identify as Khoe or San are descendants of the first diversification of the human genealogic tree, according to lead author Dr. Carina Schlebusch, from South Africa, a postdoctoral fellow at Uppsala University. These peoples belong to a branch that diverged from other peoples at least 100,000 years ago.

Human evolutionary history in Africa is much more complex than once thought. The analyses show great divergences among the various African peoples, with the deepest divergence involving the Khoe and San peoples, reported Dr. Mattias Jakobsson, who directed the study.

When modern humans began to travel outside Africa 60-70,000 years ago, there were already distinct stratification among African populations. These data suggest that there was no single geographic origin but that several populations contributed genes to the ancestral population that lead to modern humans.

The study also shows amazingly great stratification among the groups. The San people from northern Namibia and Angola diverged from the Khoe and San in South Africa as early as 25,000-40,000 years ago. The study additionally clarifies how pastoralism spread to southern Africa. The Khoe people traditionally practice cattle herding, unlike the San, who are hunters and gatherers.

The genetic analyses demonstrated that the Khoe descend from southern San groups that potentially picked up cattle-herding from East African migrants that were assimilated into the Khoe people. The researchers were also able to demonstrate genetic alterations in genes that are involved in the immune system, that regulate the structure of muscle and ultraviolet (UV) sensitivity, which may be adaptations to particular environmental conditions.

As the genetic data in the study make up the greatest divergence among now living humans, the researchers developed a novel method to assess what genetic changes were underway when modern humans emerged more than 100 000 years ago. Among the top-five genes, three regulate the structure of the skeleton, where, for example, mutations in one gene have been shown to lead to the prominent brow-ridges and rib forms suggestive of Neanderthals.

One of the co-authors, Prof. Himla Soodyall, from the University of Witwatersrand (Johannesburg, South Africa), has been studying the Khoe and San peoples for a long time. She is excited about the results and noted that they distinctly assign a prominent role to the Khoe and San peoples in the evolution of humankind.

Prof. Soodyall, together with Mattias Jakobsson and Carina Schlebusch from Uppsala University, presented the findings at the University of Witwatersrand on September 24, 2012.

Related Links:
Uppsala University
University of Witwatersrand


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.